Johnson Health Tech Co EBIT per Share
The EBIT per Share of Johnson Health Tech Co (1736.TW) as of Aug 6, 2026 is 11.83 TWD. In the previous year, EBIT per Share was 10.65 TWD — a change of 11.11% (higher).
Get this data via API
Financial Data API
EBIT per Share
11.83TWD
YoY
11.11%
Last updated:
EBIT per Share of Johnson Health Tech Co is 2026 11.83 TWD. EBIT per Share of Johnson Health Tech Co was 2025 10.65 TWD. It decreases by 11.11% higher compared to the previous year.
Access this data via the Eulerpool API
Johnson Health Tech Co Stock analysis
What does Johnson Health Tech Co do? The company Johnson Health Tech Co Ltd has been in existence for over 40 years. It was founded in 1975 in Taiwan by Peter Lo and his wife. The manufacturer of fitness equipment quickly established a reputation for high-quality products and innovations in the industry. Today, the company is the largest manufacturer of aerobic equipment in Asia and the third-largest manufacturer globally.
The business model is built on core competencies in design, innovation, and quality. They ensure that every product on the market meets the highest standard. They also place great importance on customer satisfaction and the expertise of their own employees. The company is divided into various divisions, including a subsidiary for the "Matrix" brand, which represents commercial fitness equipment.
The product ranges are designed for all types of fitness enthusiasts who want to exercise at home or in the gym. There is a particular focus on cardio training equipment (such as treadmills, cross and stepper trainers), strength training, and group training (such as indoor cycling or HIIT). Some of the well-known products include the "Matrix T7x7 treadmill," the "Horizon Elite T616 treadmill," and the "Matrix S-Force Performance Trainer." Many devices are also equipped with the latest technology, such as the Virtual Active system, which offers users realistic training options.
Over the years, Johnson Health Tech Co Ltd has received numerous awards and certifications, such as the "Certificate for Innovation Quality" and the "Certificate for High-Quality Management." Customer engagement is an essential part of successful business operations, and the company is always looking for new innovative solutions to meet the needs of its customers.
It is evident that Johnson Health Tech Co Ltd operates very successfully in the fitness industry and will continue to hold a leading position in the market in the future. The company stands for high quality, innovation, progressiveness, and customer satisfaction. Johnson Health Tech Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Johnson Health Tech Co stock
EBIT per Share of Johnson Health Tech Co is 11.83 TWD in 2026.
EBIT per Share of Johnson Health Tech Co changed from 10.65 TWD to 11.83 TWD, representing a 11.11% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Johnson Health Tech Co since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Johnson Health Tech Co
All Key Metrics — Johnson Health Tech Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth